- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
According to our latest study, the global mRNA Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Messenger RNA (mRNA) is a single-stranded long ribonucleic acid that can transmit genetic information in DNA and synthesize proteins through translation. After mRNA enters the body, specific proteins can be expressed by autologous cells, avoiding the influence of in vitro factors; it can regulate the human immune system through endogenous expression of functional proteins, and eliminate autologous threats including cancer cells. The mRNA vaccine encoding the antigenic sequence is introduced into cells through a delivery platform such as lipid nanocarriers, and then human cells produce antigens through translation to activate the immune response.
This report is a detailed and comprehensive analysis for global mRNA Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global mRNA Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global mRNA Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global mRNA Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global mRNA Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for mRNA Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global mRNA Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna, Pfizer, Zydus Cadila, Fosun Pharma and CureVAC, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
mRNA Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Preventive Vaccines
Therapeutic Vaccine
Therapeutic Drugs
Market segment by Application
Hospital
Clinic
Major players covered
Moderna
Pfizer
Zydus Cadila
Fosun Pharma
CureVAC
Sri Lankan Microorganisms
BioNtech
AstraZeneca
Janssen
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe mRNA Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of mRNA Drug, with price, sales, revenue and global market share of mRNA Drug from 2018 to 2023.
Chapter 3, the mRNA Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the mRNA Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and mRNA Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of mRNA Drug.
Chapter 14 and 15, to describe mRNA Drug sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of mRNA Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global mRNA Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Preventive Vaccines
1.3.3 Therapeutic Vaccine
1.3.4 Therapeutic Drugs
1.4 Market Analysis by Application
1.4.1 Overview: Global mRNA Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global mRNA Drug Market Size & Forecast
1.5.1 Global mRNA Drug Consumption Value (2018 & 2022 & 2029)
1.5.2 Global mRNA Drug Sales Quantity (2018-2029)
1.5.3 Global mRNA Drug Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Moderna
2.1.1 Moderna Details
2.1.2 Moderna Major Business
2.1.3 Moderna mRNA Drug Product and Services
2.1.4 Moderna mRNA Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Moderna Recent Developments/Updates
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer mRNA Drug Product and Services
2.2.4 Pfizer mRNA Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Pfizer Recent Developments/Updates
2.3 Zydus Cadila
2.3.1 Zydus Cadila Details
2.3.2 Zydus Cadila Major Business
2.3.3 Zydus Cadila mRNA Drug Product and Services
2.3.4 Zydus Cadila mRNA Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Zydus Cadila Recent Developments/Updates
2.4 Fosun Pharma
2.4.1 Fosun Pharma Details
2.4.2 Fosun Pharma Major Business
2.4.3 Fosun Pharma mRNA Drug Product and Services
2.4.4 Fosun Pharma mRNA Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Fosun Pharma Recent Developments/Updates
2.5 CureVAC
2.5.1 CureVAC Details
2.5.2 CureVAC Major Business
2.5.3 CureVAC mRNA Drug Product and Services
2.5.4 CureVAC mRNA Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 CureVAC Recent Developments/Updates
2.6 Sri Lankan Microorganisms
2.6.1 Sri Lankan Microorganisms Details
2.6.2 Sri Lankan Microorganisms Major Business
2.6.3 Sri Lankan Microorganisms mRNA Drug Product and Services
2.6.4 Sri Lankan Microorganisms mRNA Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Sri Lankan Microorganisms Recent Developments/Updates
2.7 BioNtech
2.7.1 BioNtech Details
2.7.2 BioNtech Major Business
2.7.3 BioNtech mRNA Drug Product and Services
2.7.4 BioNtech mRNA Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 BioNtech Recent Developments/Updates
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca mRNA Drug Product and Services
2.8.4 AstraZeneca mRNA Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 AstraZeneca Recent Developments/Updates
2.9 Janssen
2.9.1 Janssen Details
2.9.2 Janssen Major Business
2.9.3 Janssen mRNA Drug Product and Services
2.9.4 Janssen mRNA Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Janssen Recent Developments/Updates
3 Competitive Environment: mRNA Drug by Manufacturer
3.1 Global mRNA Drug Sales Quantity by Manufacturer (2018-2023)
3.2 Global mRNA Drug Revenue by Manufacturer (2018-2023)
3.3 Global mRNA Drug Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of mRNA Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 mRNA Drug Manufacturer Market Share in 2022
3.4.2 Top 6 mRNA Drug Manufacturer Market Share in 2022
3.5 mRNA Drug Market: Overall Company Footprint Analysis
3.5.1 mRNA Drug Market: Region Footprint
3.5.2 mRNA Drug Market: Company Product Type Footprint
3.5.3 mRNA Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global mRNA Drug Market Size by Region
4.1.1 Global mRNA Drug Sales Quantity by Region (2018-2029)
4.1.2 Global mRNA Drug Consumption Value by Region (2018-2029)
4.1.3 Global mRNA Drug Average Price by Region (2018-2029)
4.2 North America mRNA Drug Consumption Value (2018-2029)
4.3 Europe mRNA Drug Consumption Value (2018-2029)
4.4 Asia-Pacific mRNA Drug Consumption Value (2018-2029)
4.5 South America mRNA Drug Consumption Value (2018-2029)
4.6 Middle East and Africa mRNA Drug Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global mRNA Drug Sales Quantity by Type (2018-2029)
5.2 Global mRNA Drug Consumption Value by Type (2018-2029)
5.3 Global mRNA Drug Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global mRNA Drug Sales Quantity by Application (2018-2029)
6.2 Global mRNA Drug Consumption Value by Application (2018-2029)
6.3 Global mRNA Drug Average Price by Application (2018-2029)
7 North America
7.1 North America mRNA Drug Sales Quantity by Type (2018-2029)
7.2 North America mRNA Drug Sales Quantity by Application (2018-2029)
7.3 North America mRNA Drug Market Size by Country
7.3.1 North America mRNA Drug Sales Quantity by Country (2018-2029)
7.3.2 North America mRNA Drug Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe mRNA Drug Sales Quantity by Type (2018-2029)
8.2 Europe mRNA Drug Sales Quantity by Application (2018-2029)
8.3 Europe mRNA Drug Market Size by Country
8.3.1 Europe mRNA Drug Sales Quantity by Country (2018-2029)
8.3.2 Europe mRNA Drug Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific mRNA Drug Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific mRNA Drug Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific mRNA Drug Market Size by Region
9.3.1 Asia-Pacific mRNA Drug Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific mRNA Drug Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America mRNA Drug Sales Quantity by Type (2018-2029)
10.2 South America mRNA Drug Sales Quantity by Application (2018-2029)
10.3 South America mRNA Drug Market Size by Country
10.3.1 South America mRNA Drug Sales Quantity by Country (2018-2029)
10.3.2 South America mRNA Drug Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa mRNA Drug Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa mRNA Drug Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa mRNA Drug Market Size by Country
11.3.1 Middle East & Africa mRNA Drug Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa mRNA Drug Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 mRNA Drug Market Drivers
12.2 mRNA Drug Market Restraints
12.3 mRNA Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of mRNA Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of mRNA Drug
13.3 mRNA Drug Production Process
13.4 mRNA Drug Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 mRNA Drug Typical Distributors
14.3 mRNA Drug Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global mRNA Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global mRNA Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Moderna Basic Information, Manufacturing Base and Competitors
Table 4. Moderna Major Business
Table 5. Moderna mRNA Drug Product and Services
Table 6. Moderna mRNA Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Moderna Recent Developments/Updates
Table 8. Pfizer Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer Major Business
Table 10. Pfizer mRNA Drug Product and Services
Table 11. Pfizer mRNA Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Pfizer Recent Developments/Updates
Table 13. Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table 14. Zydus Cadila Major Business
Table 15. Zydus Cadila mRNA Drug Product and Services
Table 16. Zydus Cadila mRNA Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Zydus Cadila Recent Developments/Updates
Table 18. Fosun Pharma Basic Information, Manufacturing Base and Competitors
Table 19. Fosun Pharma Major Business
Table 20. Fosun Pharma mRNA Drug Product and Services
Table 21. Fosun Pharma mRNA Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Fosun Pharma Recent Developments/Updates
Table 23. CureVAC Basic Information, Manufacturing Base and Competitors
Table 24. CureVAC Major Business
Table 25. CureVAC mRNA Drug Product and Services
Table 26. CureVAC mRNA Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. CureVAC Recent Developments/Updates
Table 28. Sri Lankan Microorganisms Basic Information, Manufacturing Base and Competitors
Table 29. Sri Lankan Microorganisms Major Business
Table 30. Sri Lankan Microorganisms mRNA Drug Product and Services
Table 31. Sri Lankan Microorganisms mRNA Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Sri Lankan Microorganisms Recent Developments/Updates
Table 33. BioNtech Basic Information, Manufacturing Base and Competitors
Table 34. BioNtech Major Business
Table 35. BioNtech mRNA Drug Product and Services
Table 36. BioNtech mRNA Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. BioNtech Recent Developments/Updates
Table 38. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 39. AstraZeneca Major Business
Table 40. AstraZeneca mRNA Drug Product and Services
Table 41. AstraZeneca mRNA Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. AstraZeneca Recent Developments/Updates
Table 43. Janssen Basic Information, Manufacturing Base and Competitors
Table 44. Janssen Major Business
Table 45. Janssen mRNA Drug Product and Services
Table 46. Janssen mRNA Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Janssen Recent Developments/Updates
Table 48. Global mRNA Drug Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 49. Global mRNA Drug Revenue by Manufacturer (2018-2023) & (USD Million)
Table 50. Global mRNA Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 51. Market Position of Manufacturers in mRNA Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 52. Head Office and mRNA Drug Production Site of Key Manufacturer
Table 53. mRNA Drug Market: Company Product Type Footprint
Table 54. mRNA Drug Market: Company Product Application Footprint
Table 55. mRNA Drug New Market Entrants and Barriers to Market Entry
Table 56. mRNA Drug Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global mRNA Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 58. Global mRNA Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 59. Global mRNA Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 60. Global mRNA Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 61. Global mRNA Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 62. Global mRNA Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 63. Global mRNA Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 64. Global mRNA Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 65. Global mRNA Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Global mRNA Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Global mRNA Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 68. Global mRNA Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 69. Global mRNA Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 70. Global mRNA Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 71. Global mRNA Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 72. Global mRNA Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 73. Global mRNA Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 74. Global mRNA Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 75. North America mRNA Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 76. North America mRNA Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 77. North America mRNA Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 78. North America mRNA Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 79. North America mRNA Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 80. North America mRNA Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 81. North America mRNA Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 82. North America mRNA Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Europe mRNA Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Europe mRNA Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Europe mRNA Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 86. Europe mRNA Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 87. Europe mRNA Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 88. Europe mRNA Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 89. Europe mRNA Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe mRNA Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific mRNA Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 92. Asia-Pacific mRNA Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 93. Asia-Pacific mRNA Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 94. Asia-Pacific mRNA Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 95. Asia-Pacific mRNA Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 96. Asia-Pacific mRNA Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 97. Asia-Pacific mRNA Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 98. Asia-Pacific mRNA Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 99. South America mRNA Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 100. South America mRNA Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 101. South America mRNA Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 102. South America mRNA Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 103. South America mRNA Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 104. South America mRNA Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 105. South America mRNA Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 106. South America mRNA Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 107. Middle East & Africa mRNA Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 108. Middle East & Africa mRNA Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 109. Middle East & Africa mRNA Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 110. Middle East & Africa mRNA Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 111. Middle East & Africa mRNA Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 112. Middle East & Africa mRNA Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 113. Middle East & Africa mRNA Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 114. Middle East & Africa mRNA Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 115. mRNA Drug Raw Material
Table 116. Key Manufacturers of mRNA Drug Raw Materials
Table 117. mRNA Drug Typical Distributors
Table 118. mRNA Drug Typical Customers
List of Figures
Figure 1. mRNA Drug Picture
Figure 2. Global mRNA Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global mRNA Drug Consumption Value Market Share by Type in 2022
Figure 4. Preventive Vaccines Examples
Figure 5. Therapeutic Vaccine Examples
Figure 6. Therapeutic Drugs Examples
Figure 7. Global mRNA Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global mRNA Drug Consumption Value Market Share by Application in 2022
Figure 9. Hospital Examples
Figure 10. Clinic Examples
Figure 11. Global mRNA Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global mRNA Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global mRNA Drug Sales Quantity (2018-2029) & (K Units)
Figure 14. Global mRNA Drug Average Price (2018-2029) & (US$/Unit)
Figure 15. Global mRNA Drug Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global mRNA Drug Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of mRNA Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 mRNA Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 mRNA Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global mRNA Drug Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global mRNA Drug Consumption Value Market Share by Region (2018-2029)
Figure 22. North America mRNA Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe mRNA Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific mRNA Drug Consumption Value (2018-2029) & (USD Million)
Figure 25. South America mRNA Drug Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa mRNA Drug Consumption Value (2018-2029) & (USD Million)
Figure 27. Global mRNA Drug Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global mRNA Drug Consumption Value Market Share by Type (2018-2029)
Figure 29. Global mRNA Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global mRNA Drug Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global mRNA Drug Consumption Value Market Share by Application (2018-2029)
Figure 32. Global mRNA Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America mRNA Drug Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America mRNA Drug Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America mRNA Drug Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America mRNA Drug Consumption Value Market Share by Country (2018-2029)
Figure 37. United States mRNA Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada mRNA Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico mRNA Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe mRNA Drug Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe mRNA Drug Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe mRNA Drug Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe mRNA Drug Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany mRNA Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France mRNA Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom mRNA Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia mRNA Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy mRNA Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific mRNA Drug Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific mRNA Drug Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific mRNA Drug Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific mRNA Drug Consumption Value Market Share by Region (2018-2029)
Figure 53. China mRNA Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan mRNA Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea mRNA Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India mRNA Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia mRNA Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia mRNA Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America mRNA Drug Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America mRNA Drug Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America mRNA Drug Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America mRNA Drug Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil mRNA Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina mRNA Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa mRNA Drug Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa mRNA Drug Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa mRNA Drug Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa mRNA Drug Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey mRNA Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt mRNA Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia mRNA Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa mRNA Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. mRNA Drug Market Drivers
Figure 74. mRNA Drug Market Restraints
Figure 75. mRNA Drug Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of mRNA Drug in 2022
Figure 78. Manufacturing Process Analysis of mRNA Drug
Figure 79. mRNA Drug Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
